The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases.
about
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4Cloning of a novel membrane-linked metalloproteinase from human myeloma cellsThe tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expressionMolecular mechanisms for the conversion of zymogens to active proteolytic enzymesStructure of the catalytic domain of human fibroblast collagenase complexed with an inhibitorHigh resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertasesThe berkeleyacetals, three meroterpenes from a deep water acid mine waste Penicillium.Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Postnatal LPS Challenge Impacts Escape Learning and Expression of Plasticity Factors Mmp9 and Timp1 in Rats: Effects of Repeated Training.Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.Activation of human neutrophil procollagenase by stromelysin 2.Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.The role of plasminogen activators in the regulation of connective tissue metalloproteinases.Evidence for early fibrosis and increased airway resistance in bone marrow transplant recipient mice deficient in MMP12.Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy.Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.Serum metalloproteinases and their inhibitors: markers for malignant potential.Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation.Histomorphometric Evaluation of Cartilage Degradation using Rabbit Articular Chondrocytes Cultured in Alginate Beads - Effects of HyaluronanStromelysin-3 expression promotes tumor take in nude mice.Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.Regulation of matrix metalloproteinase expression in endothelial cells by heat-inactivated Streptococcus pneumoniaeOntogeny of MMPs and TIMPs in the murine neocortex.Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors.Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.Collagenase: a key enzyme in collagen turnover.Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature.Cell migration through extracellular matrix: membrane-type metalloproteinases make the wayMechanisms of connective tissue matrix destruction in periodontitis.Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.Expression of a biologically active murine tissue inhibitor of metalloproteinases-1 (TIMP-1) in baculovirus-infected insect cells. Purification and tissue distribution in the rat.Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
P2860
Q24322566-BC5157C2-B8E2-4CB3-AD21-F9ED19E3C1E0Q24529902-6E98AB04-1ED2-4F4A-9388-C5379BA6A8A5Q24654930-C988E9D0-2DEC-45EB-AB8C-9EB1E49205D9Q24673104-A9249C1E-F62D-4848-8884-E43CAA219A65Q27729841-0F58BF4C-FBE1-4987-AF69-3CB7F272439FQ27765120-7E54E0CC-E646-4460-A802-35A3362CE3D2Q28619008-C1ECC507-6535-4465-A324-E218EF25AA98Q33304359-03CFE19B-1423-46D5-BCA6-ABE4B1BCC44CQ33807713-9666B1D4-1561-4FA9-89CD-604C9F034B36Q33815241-3F86BAAE-BB60-4FCB-A964-3C6C6F08AFF3Q33861298-2DC5ACA5-6F31-46DA-A1EE-6EAD87E301B3Q33900860-9A78C31E-B1BD-4ECF-AEEC-EBE4E0118F5CQ33910089-A95354BF-19F1-43F2-96A3-E2DFCF331479Q34379736-8AE3B6DF-072D-42CC-B734-6480C7279C93Q34497741-39C5FC2C-85F7-435D-AA7B-9FE5E01228C8Q35240608-AF914562-108C-4E0B-9A91-BE7B772F1CB2Q35325376-C87F1416-3622-47A5-840B-528D5448F790Q35774215-5CF56585-2A93-4242-878B-5ED3642553E9Q35796413-9F3E00FE-A8C0-48A1-BA26-A7632714B7A9Q36006767-71112948-3080-40D5-B886-8DC7A748536CQ36025140-1AA749D6-0B5B-43AB-8054-ED5145777559Q36079649-CEF22DD0-2FF9-4187-ABAD-BA2C842320ADQ36081231-12D3C316-74DF-49DB-BA70-B4A18B9EBF5EQ36732007-52AF411E-BF91-410A-8F57-5CD19B02E2F5Q36735470-37948988-4977-4E7E-8BB8-C1B6853E60E5Q37354338-4EC080BE-099D-4788-95A9-F8B79B574FC6Q39506214-8D85F119-618A-4E7C-9A08-7295291D0676Q39519032-DE4078AD-6F84-4EB8-9B01-07AB7C868C4AQ40017442-A6A4563D-8A6B-4A6A-86A8-607833211412Q40023735-C54C8676-AE9C-4107-970D-DAC6E3D5AEDEQ40598423-CDAA7CFD-477D-44AE-B3BB-5FC01F55E2E6Q40670634-A327D54C-2028-4EA0-B9CA-D15FDAFF6FD0Q41481774-CDE29B8D-CE83-4028-9CB5-68468029E6D5Q41484408-8301F144-47E1-43AD-9B6F-A22293B7F911Q41741112-47E4B7AD-DFD5-442F-8F99-92FCEB80DF30Q41754986-FB85C5B0-54C6-4436-860D-E3C5FC2BD212Q41827841-AE6E5793-2488-4DF4-BA34-F8EB16470390Q42041891-DAA045AD-6EDB-45BC-8672-F8D4A9163038Q42065358-6C5C4A5A-EA4A-4A1B-9D41-4159D60BA570Q42252459-22DA07ED-C01A-49A2-8717-1AB577FEFFEC
P2860
The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The matrix metalloproteinases ...... degenerative tissue diseases.
@ast
The matrix metalloproteinases ...... degenerative tissue diseases.
@en
type
label
The matrix metalloproteinases ...... degenerative tissue diseases.
@ast
The matrix metalloproteinases ...... degenerative tissue diseases.
@en
prefLabel
The matrix metalloproteinases ...... degenerative tissue diseases.
@ast
The matrix metalloproteinases ...... degenerative tissue diseases.
@en
P2093
P1476
The matrix metalloproteinases ...... degenerative tissue diseases.
@en
P2093
P304
P356
10.1016/0167-7799(92)90214-G
P577
1992-06-01T00:00:00Z